GNPS - Urine LC-MS/MS data used for Antihypertensive Drug Screening Validation Study
This dataset contains LC-MS/MS data in positive ionisation mode of 100 spot urine samples and a pooled sample thereof that were obtained in Glasgow, UK (Institute of Cardiovascular and Medical Sciences & Glasgow Polyomics, University of Glasgow) as part the 'Next Generation Sequencing and Metabolomic Approaches in Stratification of Resistant Hypertension' study for which ethical approval was granted (NHS Ethics Approval Number -14/LO/188). Urine samples have been collected under a range of controlled settings. Informed consent was obtained from all individual study participants. Spot urine samples were taken around 11 a.m. upon a visit to the clinic, 20 1.5 ml aliquots were taken and subsequently centrifuged at 1000 g for 10 minutes after which the supernatant was stored at -80 Celcius until further analysis. A general metabolome extraction procedure was performed as done at Glasgow Polyomics, University of Glasgow, Glasgow, UK (based on Creek et al 2011): i) 5 microL urine was extracted in 200 microL chloroform/methanol/water (1:3:1) at 4 C Celcius; ii) then vortexed for 5 minutes at 4 Celcius; iii) then centrifuged for 3 minutes (13,000 g) at 4 Celcius. The resulting supernatant was stored at -80 Celcius until analysis. A pooled aliquot of all 100 urine samples was prepared prior to the LC-MS/MS runs. Full details also on LC-MS/MS metabolomics data acquisition and analysis can be found in Van der Hooft et al. 2016, Metabolomics. Chromatography and Mass Spectrometry details: The samples were analysed using a Thermo Scientific Ultimate 3000 RSLCnano system (Thermo Scientific, CA, USA). The pHILIC separation was performed with a SeQuant ZIC-pHILIC column (150 x 4.6 mm, 5 micrometer) equipped with the corresponding pre-column (Merck KGaA, Darmstadt, Germany) - the column temperature was maintained at 25 C. A linear biphasic LC gradient was conducted from 80% B to 20% B over 15 min, followed by a 2 min wash with 5% B, and 8 min re-equilibration with 80% B, where solvent B is acetonitrile and solvent A is 20 mM ammonium carbonate in water. The flow rate was 300 microL/min, column temperature was held at 25 C, injection volume was 10 microL, and samples were maintained at 4 C in the autosampler. MS equipment and settings used: The LC system was coupled to a Thermo Scientific Q-Exactive Orbitrap mass spectrometer equipped with a HESI II interface (Thermo Scientific, Hemel Hempstead, UK). The set up was calibrated (Thermo calmix) in both ionization modes and tuned for the lower m/z range before analysis. Full scan (MS1) data was acquired in positive and negative switching mode in profile mode at 35,000 resolution (at m/z 200) using 1 microscan, an AGC target of 106 cts, a maximum injection time of 250 ms, with spray voltages +3.8 and -3.0 kV, capillary temperature 320 C, heater temperature of 150 Celsius, sheath gas flow rate 40 a.u., auxiliary gas flow rate 5 a.u., sweep gas flow rate 5 a.u, a full scan mass window of 70-1050 m/z, and using m/z 74.0964 (+) and m/z 112.98563 (-) as locking masses. Fragmentation data (LC-MS/MS) was obtained in positive ionization mode as described in (van der Hooft et al 2016). Briefly, a duty cycle consisted of one full scan (MS1) event and one Top5 (or Top10) MS/MS (MS2) fragmentation event, with full scan (MS1) resolution (at m/z 200) was set to 70,000, the AGC target set to 1 x 106, and the maximum injection time set to 120 ms. MS/MS (MS2) resolution (at m/z 200) was set to 17,500, the AGC target set to 2 x 105, MS/MS maximum injection time was set to 80 ms and the underfill ratio was set to 10 %, with a resulting intensity threshold of 2.5 x 105 cts.
Main Authors: | , , |
---|---|
Format: | Dataset biblioteca |
Published: |
Wageningen University
|
Subjects: | antihypertensives, drug screening, electrospray ionisation, endogenous molecular families, human, metabolism, metabolomics, normal phase chromatography, pHILIC, positive ionisation mode, substructures, urine, |
Online Access: | https://research.wur.nl/en/datasets/gnps-urine-lc-msms-data-used-for-antihypertensive-drug-screening- |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
id |
dig-wur-nl-wurpubs-600985 |
---|---|
record_format |
koha |
institution |
WUR NL |
collection |
DSpace |
country |
Países bajos |
countrycode |
NL |
component |
Bibliográfico |
access |
En linea |
databasecode |
dig-wur-nl |
tag |
biblioteca |
region |
Europa del Oeste |
libraryname |
WUR Library Netherlands |
topic |
antihypertensives drug screening electrospray ionisation endogenous molecular families human metabolism metabolomics normal phase chromatography pHILIC positive ionisation mode substructures urine antihypertensives drug screening electrospray ionisation endogenous molecular families human metabolism metabolomics normal phase chromatography pHILIC positive ionisation mode substructures urine |
spellingShingle |
antihypertensives drug screening electrospray ionisation endogenous molecular families human metabolism metabolomics normal phase chromatography pHILIC positive ionisation mode substructures urine antihypertensives drug screening electrospray ionisation endogenous molecular families human metabolism metabolomics normal phase chromatography pHILIC positive ionisation mode substructures urine van der Hooft, Justin Barrett, Michael Padmanabhan, Sandosh GNPS - Urine LC-MS/MS data used for Antihypertensive Drug Screening Validation Study |
description |
This dataset contains LC-MS/MS data in positive ionisation mode of 100 spot urine samples and a pooled sample thereof that were obtained in Glasgow, UK (Institute of Cardiovascular and Medical Sciences & Glasgow Polyomics, University of Glasgow) as part the 'Next Generation Sequencing and Metabolomic Approaches in Stratification of Resistant Hypertension' study for which ethical approval was granted (NHS Ethics Approval Number -14/LO/188). Urine samples have been collected under a range of controlled settings. Informed consent was obtained from all individual study participants. Spot urine samples were taken around 11 a.m. upon a visit to the clinic, 20 1.5 ml aliquots were taken and subsequently centrifuged at 1000 g for 10 minutes after which the supernatant was stored at -80 Celcius until further analysis. A general metabolome extraction procedure was performed as done at Glasgow Polyomics, University of Glasgow, Glasgow, UK (based on Creek et al 2011): i) 5 microL urine was extracted in 200 microL chloroform/methanol/water (1:3:1) at 4 C Celcius; ii) then vortexed for 5 minutes at 4 Celcius; iii) then centrifuged for 3 minutes (13,000 g) at 4 Celcius. The resulting supernatant was stored at -80 Celcius until analysis. A pooled aliquot of all 100 urine samples was prepared prior to the LC-MS/MS runs. Full details also on LC-MS/MS metabolomics data acquisition and analysis can be found in Van der Hooft et al. 2016, Metabolomics. Chromatography and Mass Spectrometry details: The samples were analysed using a Thermo Scientific Ultimate 3000 RSLCnano system (Thermo Scientific, CA, USA). The pHILIC separation was performed with a SeQuant ZIC-pHILIC column (150 x 4.6 mm, 5 micrometer) equipped with the corresponding pre-column (Merck KGaA, Darmstadt, Germany) - the column temperature was maintained at 25 C. A linear biphasic LC gradient was conducted from 80% B to 20% B over 15 min, followed by a 2 min wash with 5% B, and 8 min re-equilibration with 80% B, where solvent B is acetonitrile and solvent A is 20 mM ammonium carbonate in water. The flow rate was 300 microL/min, column temperature was held at 25 C, injection volume was 10 microL, and samples were maintained at 4 C in the autosampler. MS equipment and settings used: The LC system was coupled to a Thermo Scientific Q-Exactive Orbitrap mass spectrometer equipped with a HESI II interface (Thermo Scientific, Hemel Hempstead, UK). The set up was calibrated (Thermo calmix) in both ionization modes and tuned for the lower m/z range before analysis. Full scan (MS1) data was acquired in positive and negative switching mode in profile mode at 35,000 resolution (at m/z 200) using 1 microscan, an AGC target of 106 cts, a maximum injection time of 250 ms, with spray voltages +3.8 and -3.0 kV, capillary temperature 320 C, heater temperature of 150 Celsius, sheath gas flow rate 40 a.u., auxiliary gas flow rate 5 a.u., sweep gas flow rate 5 a.u, a full scan mass window of 70-1050 m/z, and using m/z 74.0964 (+) and m/z 112.98563 (-) as locking masses. Fragmentation data (LC-MS/MS) was obtained in positive ionization mode as described in (van der Hooft et al 2016). Briefly, a duty cycle consisted of one full scan (MS1) event and one Top5 (or Top10) MS/MS (MS2) fragmentation event, with full scan (MS1) resolution (at m/z 200) was set to 70,000, the AGC target set to 1 x 106, and the maximum injection time set to 120 ms. MS/MS (MS2) resolution (at m/z 200) was set to 17,500, the AGC target set to 2 x 105, MS/MS maximum injection time was set to 80 ms and the underfill ratio was set to 10 %, with a resulting intensity threshold of 2.5 x 105 cts. |
format |
Dataset |
topic_facet |
antihypertensives drug screening electrospray ionisation endogenous molecular families human metabolism metabolomics normal phase chromatography pHILIC positive ionisation mode substructures urine |
author |
van der Hooft, Justin Barrett, Michael Padmanabhan, Sandosh |
author_facet |
van der Hooft, Justin Barrett, Michael Padmanabhan, Sandosh |
author_sort |
van der Hooft, Justin |
title |
GNPS - Urine LC-MS/MS data used for Antihypertensive Drug Screening Validation Study |
title_short |
GNPS - Urine LC-MS/MS data used for Antihypertensive Drug Screening Validation Study |
title_full |
GNPS - Urine LC-MS/MS data used for Antihypertensive Drug Screening Validation Study |
title_fullStr |
GNPS - Urine LC-MS/MS data used for Antihypertensive Drug Screening Validation Study |
title_full_unstemmed |
GNPS - Urine LC-MS/MS data used for Antihypertensive Drug Screening Validation Study |
title_sort |
gnps - urine lc-ms/ms data used for antihypertensive drug screening validation study |
publisher |
Wageningen University |
url |
https://research.wur.nl/en/datasets/gnps-urine-lc-msms-data-used-for-antihypertensive-drug-screening- |
work_keys_str_mv |
AT vanderhooftjustin gnpsurinelcmsmsdatausedforantihypertensivedrugscreeningvalidationstudy AT barrettmichael gnpsurinelcmsmsdatausedforantihypertensivedrugscreeningvalidationstudy AT padmanabhansandosh gnpsurinelcmsmsdatausedforantihypertensivedrugscreeningvalidationstudy |
_version_ |
1822265970698223616 |
spelling |
dig-wur-nl-wurpubs-6009852025-01-09 van der Hooft, Justin Barrett, Michael Padmanabhan, Sandosh Dataset GNPS - Urine LC-MS/MS data used for Antihypertensive Drug Screening Validation Study 2021 This dataset contains LC-MS/MS data in positive ionisation mode of 100 spot urine samples and a pooled sample thereof that were obtained in Glasgow, UK (Institute of Cardiovascular and Medical Sciences & Glasgow Polyomics, University of Glasgow) as part the 'Next Generation Sequencing and Metabolomic Approaches in Stratification of Resistant Hypertension' study for which ethical approval was granted (NHS Ethics Approval Number -14/LO/188). Urine samples have been collected under a range of controlled settings. Informed consent was obtained from all individual study participants. Spot urine samples were taken around 11 a.m. upon a visit to the clinic, 20 1.5 ml aliquots were taken and subsequently centrifuged at 1000 g for 10 minutes after which the supernatant was stored at -80 Celcius until further analysis. A general metabolome extraction procedure was performed as done at Glasgow Polyomics, University of Glasgow, Glasgow, UK (based on Creek et al 2011): i) 5 microL urine was extracted in 200 microL chloroform/methanol/water (1:3:1) at 4 C Celcius; ii) then vortexed for 5 minutes at 4 Celcius; iii) then centrifuged for 3 minutes (13,000 g) at 4 Celcius. The resulting supernatant was stored at -80 Celcius until analysis. A pooled aliquot of all 100 urine samples was prepared prior to the LC-MS/MS runs. Full details also on LC-MS/MS metabolomics data acquisition and analysis can be found in Van der Hooft et al. 2016, Metabolomics. Chromatography and Mass Spectrometry details: The samples were analysed using a Thermo Scientific Ultimate 3000 RSLCnano system (Thermo Scientific, CA, USA). The pHILIC separation was performed with a SeQuant ZIC-pHILIC column (150 x 4.6 mm, 5 micrometer) equipped with the corresponding pre-column (Merck KGaA, Darmstadt, Germany) - the column temperature was maintained at 25 C. A linear biphasic LC gradient was conducted from 80% B to 20% B over 15 min, followed by a 2 min wash with 5% B, and 8 min re-equilibration with 80% B, where solvent B is acetonitrile and solvent A is 20 mM ammonium carbonate in water. The flow rate was 300 microL/min, column temperature was held at 25 C, injection volume was 10 microL, and samples were maintained at 4 C in the autosampler. MS equipment and settings used: The LC system was coupled to a Thermo Scientific Q-Exactive Orbitrap mass spectrometer equipped with a HESI II interface (Thermo Scientific, Hemel Hempstead, UK). The set up was calibrated (Thermo calmix) in both ionization modes and tuned for the lower m/z range before analysis. Full scan (MS1) data was acquired in positive and negative switching mode in profile mode at 35,000 resolution (at m/z 200) using 1 microscan, an AGC target of 106 cts, a maximum injection time of 250 ms, with spray voltages +3.8 and -3.0 kV, capillary temperature 320 C, heater temperature of 150 Celsius, sheath gas flow rate 40 a.u., auxiliary gas flow rate 5 a.u., sweep gas flow rate 5 a.u, a full scan mass window of 70-1050 m/z, and using m/z 74.0964 (+) and m/z 112.98563 (-) as locking masses. Fragmentation data (LC-MS/MS) was obtained in positive ionization mode as described in (van der Hooft et al 2016). Briefly, a duty cycle consisted of one full scan (MS1) event and one Top5 (or Top10) MS/MS (MS2) fragmentation event, with full scan (MS1) resolution (at m/z 200) was set to 70,000, the AGC target set to 1 x 106, and the maximum injection time set to 120 ms. MS/MS (MS2) resolution (at m/z 200) was set to 17,500, the AGC target set to 2 x 105, MS/MS maximum injection time was set to 80 ms and the underfill ratio was set to 10 %, with a resulting intensity threshold of 2.5 x 105 cts. Wageningen University text/html https://research.wur.nl/en/datasets/gnps-urine-lc-msms-data-used-for-antihypertensive-drug-screening- 10.25345/c5ws0h https://edepot.wur.nl/575634 antihypertensives drug screening electrospray ionisation endogenous molecular families human metabolism metabolomics normal phase chromatography pHILIC positive ionisation mode substructures urine Wageningen University & Research |